Johnson & Johnson’s earnings fell 25%

The health products company reported a fall in sales in the fourth quarter due to lower demand for its Covid-19 vaccine.
Vj
All news on the site does not represent the views of the site, but we automatically submit this news and translate it using software technology on the site, rather than a human editor.